Product
Help
Pricing
About
Jobs
Log in
Get started
Source
Add to collection
The Innovation Oncology
ISSN:
3107-3395
Source type:
journal
Publisher:
Fully OA:
No
DOAJ:
No
OpenAlex ID:
S7407056701
From equations to agents: The artificial intelligence virtual cell reshaping precision oncology
2026
·
Ruochen Wei
, Boquan Wang
, et al.
·
The Innovation Oncology
·
2
PDF
Artificial intelligence derived virtual oncology
2026
·
Chunyi Lyu
, Dongbo Yao
, et al.
·
The Innovation Oncology
·
1
Beyond the “Prevention Paradox”: Prioritizing adherence-weighted effectiveness in China’s colorectal cancer screening strategy
2026
·
Xinfeng Wang
, Luyang Wei
, et al.
·
The Innovation Oncology
PDF
How does the probiotic empower immunotherapy for colorectal cancer?
2026
·
Wen-Di Liu
, Jielin Wang
, et al.
·
The Innovation Oncology
PDF
Targeting macrophages: A new frontier in cancer immunotherapy with CAR-NK cells
2026
·
Xiaokang Dai
, Dongyao Wang
·
The Innovation Oncology
PDF
Rethinking how immunotherapy is combined with chemoradiotherapy in inoperable locally advanced esophageal squamous cell carcinoma
2026
·
Tian Zhang
, Cihui Yan
, et al.
·
The Innovation Oncology
PDF
Tumor immune stemness at the interface of cancer plasticity and immune evasion
2026
·
Hengrui Liu
·
The Innovation Oncology
PDF
The Innovation Oncology: An international journal of cancer science
2026
·
Zhihao Lu
, Lin Shen
·
The Innovation Oncology
PDF
From unidirectional toxicity to bidirectional systemic interplay in Cardio-Oncology
2026
·
Jie Wang
, Rui Wang
, et al.
·
The Innovation Oncology
Redefining the tumor digital twin through cross-domain manifold mapping
2026
·
Yuanning Hu
, Wei Zong
, et al.
·
The Innovation Oncology
Tumour innervation as a regulatory layer of cancer immunity
2026
·
Denian Wang
, Zhen Fu
, et al.
·
The Innovation Oncology
New framework for precision clinical translation of gut microbiota in cancer: From individual variation to functional universality
2026
·
Ruize Qu
, Jing Weng
, et al.
·
The Innovation Oncology
PDF
Development and application of AI enabled automated drug delivery system for TACE guided by DSA
2026
·
Tianming Du
, Yin Xiong
, et al.
·
The Innovation Oncology
Practical guideline for prostate specific membrane antigen positron emission tomography / computed tomography in prostate cancer
2026
·
Chentao Jin
, Rui Zhou
, et al.
·
The Innovation Oncology
PDF
Heterogeneity, immunological mechanisms and translational prospects of tertiary lymphoid structures in cancer therapy
2026
·
Junjie Zheng
, Hui Huang
, et al.
·
The Innovation Oncology
PocketXMol: An atomic-level AI revolutionizing molecular design for precision oncology
2026
·
Zihua Wang
, Jianzhu Ma
·
The Innovation Oncology
PDF
Cracking the “undruggable”: Landmark trial sparks hope for fighting “King of Cancers”
2026
·
The Innovation Oncology News Team
·
The Innovation Oncology
PDF
Practical guideline for the diagnosis and management of central nervous system germ cell tumors
2026
·
Zhen Chen
, Bing-xin Cheng
, et al.
·
The Innovation Oncology
The value and limits of artificial intelligence in perioperative immunotherapy for gastric cancer
2026
·
Xin Xin
, Yan Li
, et al.
·
The Innovation Oncology
PDF
Efficacy and safety of fruquintinib plus chemotherapy as second-line therapy in metastatic colorectal cancer: A multicenter trial
2026
·
Wensi Zhao
, Jun Lei
, et al.
·
The Innovation Oncology
Multiview classification of pediatric medulloblastoma refines prognostic stratification and enables imaging-based risk prediction
2026
·
Adam Kraya
, Komal Rathi
, et al.
·
The Innovation Oncology
PDF
A new path for compliance-driven development: The impact of State Council Order No. 818 on biomedical innovation in China
2026
·
Lianlian Bian
, Jingli Guo
, et al.
·
The Innovation Oncology
PDF
Artificial intelligence-driven virtual knockout in cancer research: Progress, challenges, and future perspectives
2026
·
Xiangyu Wang
, Min Liu
, et al.
·
The Innovation Oncology
Targeting SQLE with ellagic acid and terbinafine: A low-cost, synergistic therapeutic strategy for bladder and lung cancer
2026
·
Qingxin Zhang
, Yihong Dong
, et al.
·
The Innovation Oncology
PDF
Efficacy of first-line immunochemotherapy by PD-L1 in HER2-negative gastric or gastroesophageal junction cancer: A meta-analysis
2026
·
Tong Xie
, Xiaotian Zhang
, et al.
·
The Innovation Oncology
PDF
Show more works
View as search
Works count:
38
Citation count:
3
H-index:
1
I10-index:
2yr mean citedness:
0.079
Year
Topic
Type
